Wellington Management Group
AIMT

Wellington Management Group’s Aimmune Therapeutics AIMT Stock Holding History

Wellington Management Group’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-800,624
Closed -$13.4M – 2033
2020
Q2 		$13.4M Sell
800,624
-114,135
-12% -$1.94M ﹤0.01% 1010
2020
Q1 		$13.2M Sell
914,759
-1,579,374
-63% -$40.4M ﹤0.01% 975
2019
Q4 		$83.5M Sell
2,494,133
-156,736
-6% -$4.38M 0.02% 612
2019
Q3 		$55.5M Buy
2,650,869
+843,597
+47% +$17.2M 0.01% 699
2019
Q2 		$37.6M Buy
1,807,272
+10,791
+0.6% +$222K 0.01% 839
2019
Q1 		$40.2M Sell
1,796,481
-64,470
-3% -$1.52M 0.01% 816
2018
Q4 		$44.5M Buy
1,860,951
+190,617
+11% +$4.93M 0.01% 748
2018
Q3 		$45.6M Sell
1,670,334
-177,811
-10% -$5.03M 0.01% 830
2018
Q2 		$49.7M Sell
1,848,145
-213,047
-10% -$6.52M 0.01% 794
2018
Q1 		$65.6M Buy
2,061,192
+2,020,789
+5,002% +$71.1M 0.01% 695
2017
Q4 		$1.53M Buy
40,403
+30,105
+292% +$971K ﹤0.01% 1809
2017
Q3 		$255K Buy
+10,298
New +$222K ﹤0.01% 2147
2017
Q2 		– Sell
-2,316,553
Closed -$50.3M – 2343
2017
Q1 		$50.3M Buy
2,316,553
+2,004,023
+641% +$41.1M 0.01% 722
2016
Q4 		$6.39M Buy
+312,530
New +$6.39M ﹤0.01% 1327

Other funds holding AIMT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group's AIMT Position: Q3 2020 in Review

Wellington Management Group sold out of Aimmune Therapeutics (AIMT) in Q3 2020, closing a stake of 800,624 shares — an estimated $13.4M sold.

Wellington Management Group first reported a position in AIMT in Q4 2016 and held it in 14 quarters. The position peaked at $83.5M in Q4 2019. 188 funds tracked by Wall St. Rank hold AIMT as of Q3 2020.

  • Wellington Management Group reported no remaining Aimmune Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Wellington Management Group sold 800,624 Aimmune Therapeutics shares in Q3 2020, an estimated $13.4M.
  • Wellington Management Group first reported a position in Aimmune Therapeutics in Q4 2016 and held it in 14 quarters.
  • Wellington Management Group's Aimmune Therapeutics position peaked at $83.5M in Q4 2019.
  • 188 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q3 2020.

Based on Wellington Management Group's 13F filing for Q3 2020, filed 16 Nov 2020.